Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer

Ai N.H. Phan; Vu T.A. Vo; Tuyen N.M. Hua; Min-Kyu Kim; Se-Young Jo; Jong-Whan Choi; Hyun-Won Kim; Jaekyoung Son; Young-Ah Suh; Yangsik Jeong

doi:10.18632/oncotarget.26710

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer

PDF | How to cite

Oncotarget. 2019; 10:1473-1473. https://doi.org/10.18632/oncotarget.26710

Metrics: PDF 1618 views | ?

Ai N.H. Phan^1,2, Vu T.A. Vo^1,2, Tuyen N.M. Hua^1,2, Min-Kyu Kim^1,2, Se-Young Jo³, Jong-Whan Choi¹, Hyun-Won Kim¹, Jaekyoung Son³, Young-Ah Suh³ and Yangsik Jeong^1,2

¹ Department of Biochemistry, Wonju College of Medicine, Yonsei University, Wonju, Gangwon-do, Republic of Korea
² Department of Global Medical Science, Institute of Lifestyle Medicine, Wonju College of Medicine, Yonsei University, Wonju, Gangwon-do, Republic of Korea
³ Asan Institute for Life Sciences, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Songpa-gu, Republic of Korea

Published: February 15, 2019

This article has been corrected: The correct Grant Support information is given below:

GRANT SUPPORT

This study was financially supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2016R1D1A3B03930581 to YS Jeong), Medical Research Center Program (2017R1A5A2015369), Yonsei University Future-leading Research Initiative of 2015 (RMS2-2015- 22-0094), JJ-2017-1 to YS Jeong, and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI17C0039).

Original article: Oncotarget. 2017; 8:82491-82505. DOI: https://doi.org/10.18632/oncotarget.19700.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26710

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer